findmyKOL
Clinical trialNCT06858397RecruitingPhase 1, PHASE2Interventional

A proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry Disease

SponsorGC Biopharma CorpEnrollment18Fabry Disesase
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Argentina
  • Centro Medico Ipam

    Rosario, Santa Fe Province, Argentina

    Sebastian Jaurretche, MD
    Recruiting
  • Hospital Italiano de Buenos Aires

    Buenos Aires, Argentina

    Marcelo Rugiero, MD
    Recruiting
South Korea
  • Pusan National University Children'S Hospital in Yangsan

    Yangsan, Gyeongsangnam-do, South Korea

    Chong Kun Cheon, MD
    Recruiting
  • Yonsei University, College of Medicine

    Seoul, South Korea

    Geu-Ru Hong, MD
    Recruiting
United States
  • David Geffen School of Medicine Ucla, Ucla Health

    Los Angeles, California, United States

    Anjay Rastogi, MD
    Recruiting
  • University of Kansas School of Medicine

    Kansas City, Kansas, United States

    Ahmad M. Tuffaha, MD
    Recruiting
  • University of Minnesota

    Minneapolis, Minnesota, United States

    Chester B. Whitley, MD
    Recruiting
  • Children'S Hospital Medical Center

    Cincinnati, Ohio, United States

    Robert J. Hopkin, MD
    Recruiting
  • University of Pittsburgh Medical Center Children'S Hoispital of Pittsburgh

    Pittsburgh, Pennsylvania, United States

    Damara Ortiz, MD
    Recruiting
  • Lysosomal and Rare Disorders Research and Treatment Center

    Fairfax, Virginia, United States

    Ozlem Goker-Alpan, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
14 May 2025
Primary completion
30 Aug 2028
Completion
30 Aug 2028
Last update posted
4 Nov 2025
Registered enrollment
18
Registry id
NCT06858397

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.